Table 1.
Participant characteristics (numbers represent mean ± standard deviation unless otherwise indicated).
| Parameter | Participants with PCa | Healthy volunteers |
|---|---|---|
| Number of participants | 20 | 6 |
| Age (years) | 70.7 ± 8.3 | 54.5 ± 12.7 |
| Body mass index (kg/m2) | 28.7 ± 6.5 | 24.8 ± 3.0 |
| Pelvis thickness (cm) | 22.3 ± 3.3 | 20.3 ± 1.4 |
| PSA (ng/mL) | 17.6 ± 14.5 | – |
| Gleason grade (from biopsy) | ||
| 3 + 3 | 0 | – |
| 3 + 4 | 9 | – |
| 4 + 3 | 7 | – |
| 4 + 4 | 4 | – |
| Number of lesions | 31 | – |
| Lesion location | ||
| PZ | 21 | – |
| TZ | 10 | – |
| Lesion volume (cm3) | 2.5 ± 3.3 | – |
| Lesion PIRADS score | ||
| 3 | 3 | – |
| 4 | 12 | – |
| 5 | 16 | – |
Abbreviations: PCa = prostate cancer, PSA = prostate-specific antigen, PZ = peripheral zone, TZ = transition zone, PIRADS = Prostate Imaging Reporting and Data System.